These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 26550923)

  • 21. Treatment and outcome data of very low birth weight infants treated with less invasive surfactant administration in comparison to intubation and mechanical ventilation in the clinical setting of a cross-sectional observational multicenter study.
    Langhammer K; Roth B; Kribs A; Göpel W; Kuntz L; Miedaner F
    Eur J Pediatr; 2018 Aug; 177(8):1207-1217. PubMed ID: 29808237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surfactant instillation in spontaneously breathing preterm infants: a systematic review and meta-analysis.
    Rigo V; Lefebvre C; Broux I
    Eur J Pediatr; 2016 Dec; 175(12):1933-1942. PubMed ID: 27678511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Less Invasive Surfactant Administration Reduces the Need for Mechanical Ventilation in Preterm Infants: A Meta-Analysis.
    Lau CSM; Chamberlain RS; Sun S
    Glob Pediatr Health; 2017; 4():2333794X17696683. PubMed ID: 28540346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Minimally Invasive Surfactant Therapy in Preterm Infants at 29-32 Weeks Gestation.
    Dargaville PA; Ali SKM; Jackson HD; Williams C; De Paoli AG
    Neonatology; 2018; 113(1):7-14. PubMed ID: 28922658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Less invasive surfactant administration (LISA): chances and limitations.
    Herting E; Härtel C; Göpel W
    Arch Dis Child Fetal Neonatal Ed; 2019 Nov; 104(6):F655-F659. PubMed ID: 31296694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update.
    Sweet DG; Carnielli V; Greisen G; Hallman M; Ozek E; Te Pas A; Plavka R; Roehr CC; Saugstad OD; Simeoni U; Speer CP; Vento M; Visser GHA; Halliday HL
    Neonatology; 2019; 115(4):432-450. PubMed ID: 30974433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of less invasive surfactant administration (LISA) in the United States with review of the literature.
    Kurepa D; Perveen S; Lipener Y; Kakkilaya V
    J Perinatol; 2019 Mar; 39(3):426-432. PubMed ID: 30635595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratory distress syndrome on non-invasive positive pressure ventilation-a randomized controlled trial.
    Gupta BK; Saha AK; Mukherjee S; Saha B
    Eur J Pediatr; 2020 Aug; 179(8):1287-1293. PubMed ID: 32462483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimally invasive surfactant therapy versus intubation for surfactant administration in very low birth weight infants with respiratory distress syndrome.
    Wang XA; Chen LJ; Chen SM; Su PH; Chen JY
    Pediatr Neonatol; 2020 Apr; 61(2):210-215. PubMed ID: 31818537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surfactant therapy in premature babies: SurE or InSurE.
    Jena SR; Bains HS; Pandita A; Verma A; Gupta V; Kallem VR; Abdullah M; Kawdiya A; On Behalf Of Sure Group
    Pediatr Pulmonol; 2019 Nov; 54(11):1747-1752. PubMed ID: 31424177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Less Invasive Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome.
    Halim A; Shirazi H; Riaz S; Gul SS; Ali W
    J Coll Physicians Surg Pak; 2019 Mar; 29(3):226-330. PubMed ID: 30823947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative efficacy of methods for surfactant administration: a network meta-analysis.
    Bellos I; Fitrou G; Panza R; Pandita A
    Arch Dis Child Fetal Neonatal Ed; 2021 Sep; 106(5):474-487. PubMed ID: 33452218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of less invasive surfactant administration (LISA) via a gastric tube on the treatment of respiratory distress syndrome in premature infants aged 32 to 36 weeks.
    Yang G; Hei M; Xue Z; Zhao Y; Zhang X; Wang C
    Medicine (Baltimore); 2020 Feb; 99(9):e19216. PubMed ID: 32118723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Less invasive surfactant administration: a word of caution.
    De Luca D; Shankar-Aguilera S; Centorrino R; Fortas F; Yousef N; Carnielli VP
    Lancet Child Adolesc Health; 2020 Apr; 4(4):331-340. PubMed ID: 32014122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants.
    Kaniewska U; Gulczyńska E
    Dev Period Med; 2019; 23(3):163-171. PubMed ID: 31654994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of surfactant administration through a thin catheter in the delivery room: A quality control chart analysis coupled with a propensity score matched cohort study in preterm infants.
    Berneau P; Nguyen Phuc Thu T; Pladys P; Beuchée A
    PLoS One; 2018; 13(12):e0208252. PubMed ID: 30540816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nebulised surfactant to reduce severity of respiratory distress: a blinded, parallel, randomised controlled trial.
    Minocchieri S; Berry CA; Pillow JJ;
    Arch Dis Child Fetal Neonatal Ed; 2019 May; 104(3):F313-F319. PubMed ID: 30049729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is Less Invasive Surfactant Administration Necessary or "Only" Helpful or Just a Fashion?
    Lista G; Bresesti I; Fabbri L
    Am J Perinatol; 2018 May; 35(6):530-533. PubMed ID: 29694989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of different surfactant administrations on cerebral autoregulation in preterm infants with respiratory distress syndrome.
    Li XF; Cheng TT; Guan RL; Liang H; Lu WN; Zhang JH; Liu MY; Yu X; Liang J; Sun L; Zhang L
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):801-805. PubMed ID: 27924521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catheter and Laryngeal Mask Endotracheal Surfactant Therapy: the CALMEST approach as a novel MIST technique.
    Vannozzi I; Ciantelli M; Moscuzza F; Scaramuzzo RT; Panizza D; Sigali E; Boldrini A; Cuttano A
    J Matern Fetal Neonatal Med; 2017 Oct; 30(19):2375-2377. PubMed ID: 27780385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.